BPC-157 Oral vs Injection: Complete Comparison

BPC-157 is naturally derived from gastric juice proteins, which gives it inherent stability in the GI environment — unlike most peptides that are rapidly degraded by stomach acid and digestive enzymes. Oral BPC-157 maintains local activity throughout the GI tract, making it particularly effective for conditions like gastric ulcers, intestinal inflammation, and leaky gut.

Some systemic absorption does occur, meaning oral BPC-157 may provide benefits beyond the gut. However, the bioavailability is lower than injection, so systemic effects are less pronounced.

Subcutaneous or intramuscular injection of BPC-157 delivers the peptide directly into systemic circulation, bypassing GI degradation. This provides higher bioavailability and allows for targeted local effects when injected near an injury site.

For musculoskeletal injuries — tendons, ligaments, muscles, and joints — injection is generally preferred. Animal studies consistently show accelerated healing when BPC-157 is administered close to the injury, promoting angiogenesis and growth factor upregulation at the repair site.

For Gut Healing: Oral administration is preferred. Direct contact with the GI mucosa provides the highest local concentration where it's needed most. Studies show oral BPC-157 effectively heals gastric ulcers, intestinal lesions, and inflammatory bowel models.

For Injuries & Recovery: Injection is preferred. Subcutaneous injection near the injury site provides both systemic and targeted local effects. Higher bioavailability means more peptide reaches the damaged tissue.

For General Wellness: Oral is more convenient and may provide adequate systemic benefits for general health maintenance. Many users start oral and switch to injection for specific injuries.

Oral BPC-157 doses in research typically range from 200-500 mcg daily, often taken on an empty stomach. Injectable doses range from 200-300 mcg once or twice daily, administered subcutaneously. Due to lower oral bioavailability, some protocols use higher oral doses to compensate.

Both forms are generally well-tolerated in reported use with minimal side effects. Always consult a healthcare provider for guidance on any peptide protocol.

Ascension Peptides offers BPC-157 in both injectable and oral-compatible formats with third-party certificates of analysis. Purity (≥98%) and proper storage are critical for maintaining peptide integrity, especially for oral formulations that must survive the GI environment.